Skip to main content
Vidhya Karivedu, MD, Oncology, Durham, NC

VidhyaKariveduMD

Oncology Durham, NC

Head & Neck Cancer

Assistant Professor of Medicine

Dr. Karivedu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Karivedu's full profile

Already have an account?

Education & Training

  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Cleveland Clinic Foundation/Fairview Hospital
    Cleveland Clinic Foundation/Fairview HospitalChief Residency, Internal Medicine, 2015 - 2016
  • Cleveland Clinic Foundation/Fairview Hospital
    Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 2013 - 2016
  • Sri Venkatesvara Medical College NTR
    Sri Venkatesvara Medical College NTRClass of 2011

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2025
  • NC State Medical License
    NC State Medical License 2023 - 2024
  • OH State Medical License
    OH State Medical License 2016 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Metformin treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) patients induces an anti-tumorigenic immune response. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

  • University of Cincinnati Cancer Experts Present Research at ASCO Annual Meeting
    University of Cincinnati Cancer Experts Present Research at ASCO Annual MeetingMay 25th, 2023